title: Editorial: tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis.
authors.affiliation: Department of Gastroenterology, Alfred Hospital, Melbourne, Vic., Australia.
authors.forename: K M
authors.initials: KM
authors.lastname: Taylor
authors.affiliation: Department of Gastroenterology, Alfred Hospital, Melbourne, Vic., Australia. m.sparrow@alfred.org.au.
authors.forename: M P
authors.initials: MP
authors.lastname: Sparrow
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016559:Tacrolimus / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000627:therapeutic use
chemical_list: D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; D016559:Tacrolimus